LakeShore Biopharma Stock Forecast - Naive Prediction

LSBDelisted Stock   0.63  0.00  0.00%   
The Naive Prediction forecasted value of LakeShore Biopharma Co on the next trading day is expected to be 0.64 with a mean absolute deviation of 0.04 and the sum of the absolute errors of 2.73. LakeShore Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast LakeShore Biopharma stock prices and determine the direction of LakeShore Biopharma Co's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of LakeShore Biopharma's historical fundamentals, such as revenue growth or operating cash flow patterns.
At the present time, the value of RSI of LakeShore Biopharma's share price is approaching 39. This indicates that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling LakeShore Biopharma, making its price go up or down.

Momentum 39

 Sell Extended

 
Oversold
 
Overbought
The successful prediction of LakeShore Biopharma's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with LakeShore Biopharma Co, which may create opportunities for some arbitrage if properly timed.
Using LakeShore Biopharma hype-based prediction, you can estimate the value of LakeShore Biopharma Co from the perspective of LakeShore Biopharma response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of LakeShore Biopharma Co on the next trading day is expected to be 0.64 with a mean absolute deviation of 0.04 and the sum of the absolute errors of 2.73.

LakeShore Biopharma after-hype prediction price

    
  USD 0.6  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

LakeShore Biopharma Additional Predictive Modules

Most predictive techniques to examine LakeShore price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for LakeShore using various technical indicators. When you analyze LakeShore charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
A naive forecasting model for LakeShore Biopharma is a special case of the moving average forecasting where the number of periods used for smoothing is one. Therefore, the forecast of LakeShore Biopharma Co value for a given trading day is simply the observed value for the previous period. Due to the simplistic nature of the naive forecasting model, it can only be used to forecast up to one period.

LakeShore Biopharma Naive Prediction Price Forecast For the 24th of January

Given 90 days horizon, the Naive Prediction forecasted value of LakeShore Biopharma Co on the next trading day is expected to be 0.64 with a mean absolute deviation of 0.04, mean absolute percentage error of 0, and the sum of the absolute errors of 2.73.
Please note that although there have been many attempts to predict LakeShore Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that LakeShore Biopharma's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

LakeShore Biopharma Stock Forecast Pattern

Backtest LakeShore BiopharmaLakeShore Biopharma Price PredictionBuy or Sell Advice 

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of LakeShore Biopharma stock data series using in forecasting. Note that when a statistical model is used to represent LakeShore Biopharma stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria112.6983
BiasArithmetic mean of the errors None
MADMean absolute deviation0.0447
MAPEMean absolute percentage error0.0663
SAESum of the absolute errors2.7283
This model is not at all useful as a medium-long range forecasting tool of LakeShore Biopharma Co. This model is simplistic and is included partly for completeness and partly because of its simplicity. It is unlikely that you'll want to use this model directly to predict LakeShore Biopharma. Instead, consider using either the moving average model or the more general weighted moving average model with a higher (i.e., greater than 1) number of periods, and possibly a different set of weights.

Predictive Modules for LakeShore Biopharma

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as LakeShore Biopharma. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of LakeShore Biopharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.030.607.27
Details
Intrinsic
Valuation
LowRealHigh
0.030.537.20
Details

LakeShore Biopharma After-Hype Price Prediction Density Analysis

As far as predicting the price of LakeShore Biopharma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in LakeShore Biopharma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of LakeShore Biopharma, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

LakeShore Biopharma Estimiated After-Hype Price Volatility

In the context of predicting LakeShore Biopharma's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on LakeShore Biopharma's historical news coverage. LakeShore Biopharma's after-hype downside and upside margins for the prediction period are 0.03 and 7.27, respectively. We have considered LakeShore Biopharma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
0.63
0.60
After-hype Price
7.27
Upside
LakeShore Biopharma is out of control at this time. Analysis and calculation of next after-hype price of LakeShore Biopharma is based on 3 months time horizon.

LakeShore Biopharma Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as LakeShore Biopharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading LakeShore Biopharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with LakeShore Biopharma, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.84 
6.67
  0.03 
  0.02 
7 Events / Month
4 Events / Month
In about 7 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
0.63
0.60
4.76 
22,233  
Notes

LakeShore Biopharma Hype Timeline

On the 23rd of January LakeShore Biopharma is traded for 0.63. The entity has historical hype elasticity of -0.03, and average elasticity to hype of competition of 0.02. LakeShore is projected to decline in value after the next headline, with the price expected to drop to 0.6. The average volatility of media hype impact on the company price is over 100%. The price depreciation on the next news is expected to be -4.76%, whereas the daily expected return is now at -0.84%. The volatility of related hype on LakeShore Biopharma is about 27791.67%, with the expected price after the next announcement by competition of 0.65. About 88.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.49. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. LakeShore Biopharma recorded a loss per share of 0.73. The entity had not issued any dividends in recent years. The firm had 1:10 split on the 4th of October 2024. Considering the 90-day investment horizon the next projected press release will be in about 7 days.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

LakeShore Biopharma Related Hype Analysis

Having access to credible news sources related to LakeShore Biopharma's direct competition is more important than ever and may enhance your ability to predict LakeShore Biopharma's future price movements. Getting to know how LakeShore Biopharma's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how LakeShore Biopharma may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
ANPCAnpac Bio Medical 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
LMNLLiminal BioSciences 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
FRLNFreeline Therapeutics Holdings 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
SERSerina Therapeutics 0.35 20 per month 0.00 (0.13) 8.95 (8.66) 23.77 
GMTXGemini Therapeutics 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
TRAWTraws Pharma(0.34)10 per month 8.31  0.02  17.70 (10.71) 58.96 
ALLKAllakos 0.35 3 per month 1.75  0.06  4.00 (4.00) 45.45 
ELEVElevation Oncology(0.06)7 per month 3.35  0.04  9.09 (6.67) 29.95 
MEIPMEIP Old(0.06)11 per month 7.01  0.09  11.67 (11.72) 60.63 
IVCInvacare 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 

LakeShore Biopharma Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with LakeShore Biopharma stock to make a market-neutral strategy. Peer analysis of LakeShore Biopharma could also be used in its relative valuation, which is a method of valuing LakeShore Biopharma by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

LakeShore Biopharma Market Strength Events

Market strength indicators help investors to evaluate how LakeShore Biopharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading LakeShore Biopharma shares will generate the highest return on investment. By undertsting and applying LakeShore Biopharma stock market strength indicators, traders can identify LakeShore Biopharma Co entry and exit signals to maximize returns.

LakeShore Biopharma Risk Indicators

The analysis of LakeShore Biopharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in LakeShore Biopharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting lakeshore stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Story Coverage note for LakeShore Biopharma

The number of cover stories for LakeShore Biopharma depends on current market conditions and LakeShore Biopharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that LakeShore Biopharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about LakeShore Biopharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Other Macroaxis Stories

Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios

LakeShore Biopharma Short Properties

LakeShore Biopharma's future price predictability will typically decrease when LakeShore Biopharma's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of LakeShore Biopharma Co often depends not only on the future outlook of the potential LakeShore Biopharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. LakeShore Biopharma's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding106.9 M
Cash And Short Term Investments28.1 M
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Other Consideration for investing in LakeShore Stock

If you are still planning to invest in LakeShore Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the LakeShore Biopharma's history and understand the potential risks before investing.
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Bonds Directory
Find actively traded corporate debentures issued by US companies
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals